The committee noted that Kemsa could only supply 50 to 60 per cent of counties’ needs.
Early this month, the Council of Governors also expressed its intention to stop buying drugs from Kemsa.
The scandal-ridden Kenya Medical Supplies Authority (Kemsa) will lose its monopoly in the supply of medical products and technologies to counties and government agencies if senators adopt a report of an ad hoc committee.
In a report tabled before the Senate last week, the committee investigating the Sh63 billion Managed Equipment Service (MES) scandal wants government agencies and counties to have authority to procure medical products from other entities apart from Kemsa.
